SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
CERUS
(NQNM:CERS Last Sale: 5.2 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (CERS : $5.2)
$852,566 million Market Cap at Market Close, July 1, 2022
Employs 100.
Biomedics SubIndustry up .00% / Health Industry up .00% Today
2525 Stanwell Drive Suite 300 Research Report Earnings Snapshot - Last 11/04/18
Concord, CA 94520 Fact Sheet
Phone: 925-288-6000 Financial Statements
Peer Comparison
Annual Reports

Claes Glassell, Chmn./CEO, William J. Dawson, CFO.
Developing a treatment for donor blood to increase the safety of transfusions. IPO at $12 January 30, 1997. Raised $24 MM, selling 2 MM shares, 22% of the outstanding. Lead Manager: Morgan Stanley Dean Witter. Secondary sold 4.5 million shares at $8.75 March 16, 2006.
Historical Charts    Technical Analysis
No Historical Data available for CERS

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common CERS $5.2 $5.2 0 .0 $5.12 $5.9 2,892,196 $5.12 $5.9 163,954,958
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $852,565,782

A55
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex